AAAS is concerned about how some of the key terms in the bill could be interpreted or misinterpreted, especially terms such as "materials", "data", and "reproducible". Would the agency be excluded from utilizing research that involved physical specimens or biological materials that are not easily accessible? How would the agency address research that combines both public and private data?